Benralizumab rapidly improves asthma control in Austrian real-life severe eosinophilic asthmatics

Allergy. 2020 Dec;75(12):3272-3275. doi: 10.1111/all.14441. Epub 2020 Jul 23.

Authors

Andreas Renner¹, Katharina Marth¹, Karin Patocka¹, Marco Idzko², Wolfgang Pohl¹

Affiliations

¹ Karl Landsteiner Institute for Clinical and Experimental Pneumology, Hietzing Hospital, Vienna, Austria.
² Department of Pulmonology, Medical University of Vienna, Vienna, Austria.

PMID: 32526056
DOI: 10.1111/all.14441

No abstract available

Publication types

Letter

MeSH terms

Anti-Asthmatic Agents* / therapeutic use
Antibodies, Monoclonal, Humanized / therapeutic use
Asthma* / drug therapy
Austria
Eosinophils
Humans

Substances

Anti-Asthmatic Agents
Antibodies, Monoclonal, Humanized
benralizumab